• Oxford BioDynamics Plc shares declined 21.51% on 26 June 2026, making it one of the weakest performers on the FTSE AIM market.
• The decline reflected cautious investor sentiment across several AIM-listed healthcare and professional services companies.
Healthcare has once again emerged as one of the most closely followed sectors in the UK equity market. Investors continue to favour defensive businesses with resilient earnings, strong cash flows, global operations, and long-term innovation pipelines. While interest rate expectations, geopolitical developments, and global …
The latest market screen placed Cresco Labs Reigniting Cannabis Investor Interest (CN:CL) among the Canadian shares attracting unusual attention, and that alone is enough to put the name on trader watchlists. A top-gainer ranking does not automatically mean a business has changed overnight, but …
The latest market screen placed Cheelcare (TSXV:CHER) among the Canadian shares attracting unusual attention, and that alone is enough to put the name on trader watchlists. A top-gainer ranking does not automatically mean a business has changed overnight, but it does indicate that buyers …
The latest market screen placed COSCIENS Biopharma (TSX:CSCI) among the Canadian shares attracting unusual attention, and that alone is enough to put the name on trader watchlists. A top-gainer ranking does not automatically mean a business has changed overnight, but it does indicate that …
The latest market screen placed Curaleaf (TSX:CURA) among the Canadian shares attracting unusual attention, and that alone is enough to put the name on trader watchlists. A top-gainer ranking does not automatically mean a business has changed overnight, but it does indicate that buyers …
As demand for innovative biological tools continues to increase, Aptamer Group is seeking to expand its commercial footprint through strategic partnerships, licensing opportunities and product development.
As healthcare systems increasingly adopt precision medicine, demand for diagnostic tools capable of delivering personalized insights continues to grow. Verici Dx operates in this expanding segment by developing tests that aim to improve transplant outcomes, reduce complications, and support more efficient use of healthcare …
IntroductionThe latest market screen placed Bausch Health’s Turnaround Trade (TSX:BHC) among the Canadian shares attracting unusual attention, and that alone is enough to put the name on trader watchlists. A top-gainer ranking does not automatically mean a business has changed overnight, but it does …